Avinger, Inc. AVGR NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score

17/100

0/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Avinger, Inc. (AVGR) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 16/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

17/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

未來

40/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

20/100

→ Income

✗

成长

30/100

→ Income

✗

收入

10/100

→ Income

估值概览 — AVGR

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.05

EV/EBITDA0.0

每股数据

EPS (TTM)$-23.31

每股账面价值$0.00

每股营收$9.74

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2014	$-389,805.00	$11.21M	$-31.96M	-285.1%
2015	$-450,895.00	$10.71M	$-47.34M	-441.9%
2016	$-283,475.00	$19.21M	$-56.13M	-292.1%
2017	$-175,928.00	$9.93M	$-48.73M	-490.6%
2018	$-7,736.66	$7.92M	$-27.56M	-348.2%
2019	$-818.60	$9.13M	$-19.75M	-216.3%
2020	$-120.80	$8.76M	$-19.82M	-226.3%
2021	$-65.79	$10.13M	$-20.71M	-204.4%
2022	$-41.83	$8.27M	$-17.43M	-210.6%
2023	$-23.31	$7.65M	$-18.32M	-239.4%